Table 1.
Characteristics of 132 patients with symptomatic portal hypertension
| Characteristic | Data |
|---|---|
| Age, mean ± SD, years | 49.98 ± 12.00 |
| Sex, n (%) | |
| Male | 56 (42.4%) |
| Female | 76 (57.6%) |
| Primary liver disease, n (%) | |
| AIH | 2 (1.52%) |
| ALD + HBV | 1 (0.76%) |
| ALD | 7 (5.30%) |
| DILI | 2 (1.52%) |
| HBV | 82 (62.12%) |
| HCV | 7 (5.30%) |
| CC | 6 (4.55%) |
| IPH | 12 (9.09%) |
| NASH | 3 (2.27%) |
| PBC | 8 (6.06%) |
| PBC-AIH | 2 (1.52%) |
| History of upper gastrointestinal bleeding, n (%) | |
| NO | 21 (15.91%) |
| YES | 111 (84.09%) |
| Preoperative varicose veins, n (%) | |
| NO | 2 (1.65%) |
| Mild | 6 (4.96%) |
| Moderate | 38 (31.40%) |
| Severe | 75 (61.98%) |
| Laboratory tests before PSPD, mean ± SD | |
| Leucocyte count (*109/L) | 2.17 ± 0.99 |
| Platelet count (*109/L) | 58.61 ± 37.76 |
| Spleen diameter before PSPD, mean ± SD, mm | 138.48 ± 20.38 |
| CHILD–PUGH grade, n (%) | |
| A | 99 (75%) |
| B | 33 (25%) |
| Preoperative PVT, n (%) | |
| NO | 85 (64.39%) |
| Yes | 47 (35.61%) |
| Follow-up, n (%) | |
| 7days | 132 (100%) |
| 6months | 89 (67.42%) |
| 1 year | 63 (47.73%) |
| 2 years | 43 (32.58%) |
| 3 years | 26 (19.70%) |
| ≥ 4 years | 22 (16.67%) |
Data are expressed as mean ± SD or number (percent) of patients
AIH autoimmune hepatitis, ALD alcoholic liver disease, DILI drug-induced liver injury, HBV hepatitis B, HCV hepatitis C, CC cryptogenic cirrhosis, IPH idiopathic portal hypertension, NASH non-alcoholic steatohepatitis, PBC primary biliary cirrhosis, PSPD partial splenectomy and pericardial devascularization, PVT portal vein thrombosis